2024-513863-21-00CompletedPhase 1
A Study to Learn if the Study Medicines Called Itraconazole and Cyclosporine Change How the Body Processes the Other Study Medicine Called Danuglipron in Healthy Adults
Source: EU CTIS (euclinicaltrials.eu) · Last updated 24 Jun 2025
- Status (registry)
- Completed
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 16 (actual)
- First submitted
- 12 Jun 2024
- Start date
- 1 Nov 2024
- Lead sponsor
- Pfizer Inc.
- EU CT number
- 2024-513863-21-00
What you commit to
- Study type: Interventional · Phase 1
- Participants enrolled: 16
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pfizer Clinical Research Unit | Brussels | Belgium | Completed |
This page is information, not medical advice. Discuss any trial with your doctor.